Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
HRT [AMEX]
Arrhythmia Research Technology Inc.
Index- P/E- EPS (ttm)-0.06 Insider Own4.40% Shs Outstand2.74M Perf Week0.94%
Market Cap17.65M Forward P/E- EPS next Y- Insider Trans14.21% Shs Float2.06M Perf Month-3.01%
Income-0.10M PEG- EPS next Q- Inst Own11.90% Short Float0.55% Perf Quarter-4.31%
Sales23.10M P/S0.76 EPS this Y-51.20% Inst Trans23.01% Short Ratio1.13 Perf Half Y31.97%
Book/sh2.53 P/B2.55 EPS next Y- ROA-1.20% Target Price- Perf Year87.76%
Cash/sh0.07 P/C88.23 EPS next 5Y- ROE-3.10% 52W Range3.09 - 8.00 Perf YTD103.15%
Dividend- P/FCF- EPS past 5Y-64.40% ROI-28.40% 52W High-19.50% Beta0.95
Dividend %- Quick Ratio0.70 Sales past 5Y-1.10% Gross Margin17.30% 52W Low108.41% ATR0.32
Employees108 Current Ratio1.10 Sales Q/Q-40.00% Oper. Margin0.00% RSI (14)48.15 Volatility2.80% 5.31%
OptionableNo Debt/Eq0.36 EPS Q/Q108.50% Profit Margin-0.90% Rel Volume0.58 Prev Close6.34
ShortableYes LT Debt/Eq0.29 EarningsNov 19 Payout- Avg Volume10.05K Price6.44
Recom- SMA201.42% SMA50-4.73% SMA2009.79% Volume5,860 Change1.58%
30-Oct-14 01:30PM  Micron Products, Inc. Appoints Albert McGrath as Vice President of Operations GlobeNewswire
19-Aug-14 01:04PM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Financials EDGAR Online Financials
08-Aug-14 06:00AM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
07-Aug-14 04:05PM  Arrhythmia Research Technology, Inc. Reports 28.1% Revenue Growth; Delivered $0.09 in Earnings per Share for Second Quarter 2014 GlobeNewswire
01-Jul-14 06:00AM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
27-May-14 05:09PM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
09-May-14 02:41PM  5 Stocks Ready for Breakouts at TheStreet +9.30%
08:51AM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online
06:55AM  Arrhythmia Research Technology, Inc. Reports Earnings Per Share of $0.09 on 6.9% Increase in First Quarter 2014 Sales GlobeNewswire
27-Mar-14 01:04PM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Financials EDGAR Online Financials
21-Mar-14 04:18PM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial EDGAR Online
04:15PM  Arrhythmia Research Technology, Inc. Announces Fourth Quarter and 2013 Year End Results Marketwired
11-Mar-14 11:47AM  Needing Smarter, More Cost-Effective Production, Medical OEMs Turn to Contract Manufacturing PR Newswire -15.02%
19-Feb-14 02:25PM  Arrhythmia Research Technology, Inc. Announces Supply Agreement With Blue Belt Technologies, Inc. Marketwired
14-Feb-14 05:15PM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
09:21AM  Arrhythmia Research Technology, Inc. Announces Date of Annual Meeting of Shareholders Marketwired
14-Jan-14 08:11AM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
10-Jan-14 06:00AM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders EDGAR Online
23-Dec-13 09:13AM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered EDGAR Online +12.06%
09:06AM  Arrhythmia Research Technology, Inc. Announces Closing of Private Placement Marketwired
Arrhythmia Research Technology, Inc. manufactures and sells components, devices, and equipment for medical, military, law enforcement, industrial, and automotive applications. It produces sells silver/silver chloride coated and conductive resin sensors used as component parts to manufacture integrated disposable electrophysiological sensors, which are used in the monitoring of electrical signals in various medical applications, as well as produces orthopedic implants. The company also licenses customizable proprietary signal-averaged electrocardiography software under Predictor brand that is used in research and clinical environments to diagnose the risk of certain heart arrhythmias. In addition, it performs custom thermoplastic injection molding, as well as provides design, engineering, and production services and management. The company operates in the United States, Canada, Europe, the Pacific Rim, and other countries. Arrhythmia Research Technology, Inc. was founded in 1981 and is based in Fitchburg, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Emma Salvatore JrPRESIDENT and CEOAug 19Sale7.208,60061,9572,027Aug 20 04:40 PM
Emma Salvatore JrPRESIDENT and CEOAug 18Sale7.224,40031,7900Aug 20 04:40 PM
Chambers Jason RussellDirectorAug 14Sale7.305,00036,500100,043Aug 14 02:34 PM